2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. IGF-1R
  5. IGF-1R Antagonist

IGF-1R Antagonist

IGF-1R Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P99274
    Xentuzumab
    		Antagonist 99.71%
    Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation.